DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of …,

DelMar continues to actively enroll patients in both trial arms of the clinical study, even in light of the COVID-19 pandemic. DelMar previously announced …, DelMar continues to actively enroll patients in both trial arms of the clinical study, even in light of the COVID-19 pandemic. DelMar previously announced …, Read More

Scroll to Top